All PlansCoverageMedium impact
Policies recently reviewed for annual update
Blue Cross Blue Shield of Rhode Island·RI · Endocrinology, Neurology, Orthopedics +3 more·Physician / Facility
Effective date
Feb 1, 2022
We identified it
Jun 19, 2026
Summary
BCBS Rhode Island has completed annual policy reviews for six specific medical policies as of February 1, 2022. The updated policies cover bone mineral density studies, non-reimbursable services, occipital nerve stimulation, sphenopalatine ganglion blocks, diabetic therapeutic shoes, and transesophageal endoscopic GERD treatments.
Action Required
Immediately: Billing team must review the six updated policies on bcbsri.com Provider section to identify any coverage or billing changes for bone mineral density studies, occipital nerve stimulation insertion, sphenopalatine ganglion blocks for headache, diabetic therapeutic shoes, and transesophageal endoscopic GERD treatments. Update billing procedures and encounter forms based on any policy changes found.